Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 1.254
-0.036 (-2.79%)
Oct 2, 2026, 5:35 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €91.16 million as of October 2, 2026. Its market cap has decreased by -54.66% in one year.
Market Cap
91.16M
Enterprise Value
15.59M
Revenue
55.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.25
ChartMarket Cap Chart
Since February 7, 2007, Cellectis's market cap has decreased from 100.59M to 91.16M, a decrease of -9.38%. That is a compound annual growth rate of -0.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 91.16M | -69.95% |
| Dec 31, 2025 | 303.40M | 158.68% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valerio Therapeutics Société anonyme | 275.20M |
| Transgene | 199.66M |
| Innate Pharma | 128.18M |
| Sensorion | 80.75M |
| ABIONYX Pharma | 74.43M |
| OSE Immunotherapeutics | 52.97M |
| Adocia | 52.36M |
| THX Pharma Société Anonyme | 48.63M |